InvestorsHub Logo
Followers 76
Posts 10333
Boards Moderated 0
Alias Born 02/23/2010

Re: DrBones post# 272460

Friday, 09/13/2019 7:30:25 AM

Friday, September 13, 2019 7:30:25 AM

Post# of 403767
...As Alfasigma USA moves forward with Zelnorm, Downey said the company is expanding its pipeline in order to grow its presence in the pharmaceutical space. In July, the company licensed Brilacidin from Innovation Pharmaceuticals for more than $24 million. Alfasigma will develop Brilacidin for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis.